Skopos Labs, Inc. Takeda Pharmaceutical CO LTD Transaction History
Skopos Labs, Inc.
- $453 Million
- Q1 2025
A detailed history of Skopos Labs, Inc. transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Skopos Labs, Inc. holds 12,176 shares of TAK stock, worth $183,614. This represents 0.04% of its overall portfolio holdings.
Number of Shares
12,176
Previous 1,229
890.72%
Holding current value
$183,614
Previous $16,000
1031.25%
% of portfolio
0.04%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding TAK
# of Institutions
360Shares Held
67.4MCall Options Held
1.72MPut Options Held
186K-
Capital Research Global Investors Los Angeles, CA13.2MShares$199 Million0.04% of portfolio
-
Morgan Stanley New York, NY5.7MShares$86 Million0.01% of portfolio
-
Goldman Sachs Group Inc New York, NY5.32MShares$80.2 Million0.01% of portfolio
-
Brandes Investment Partners, LP La Jolla, CA3.5MShares$52.8 Million0.57% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.43MShares$51.8 Million0.1% of portfolio
About TAKEDA PHARMACEUTICAL CO LTD
- Ticker TAK
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 3,109,050,112
- Market Cap $46.9B
- Description
- Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...